OncoCyte Aktie
WKN DE: A2ACBH / ISIN: US68235C1071
24.03.2025 23:00:46
|
OncoCyte Corporation (OCX) Q4 Sales Increase
(RTTNews) - OncoCyte Corporation (OCX) (OCX) revealed Loss for fourth quarter of -$33.51 million
The company's bottom line came in at -$33.51 million, or -$1.93 per share. This compares with -$15.99 million, or -$1.96 per share, last year.
The company's revenue for the period rose 373.2% to $1.486 million from $0.314 million last year.
OncoCyte Corporation (OCX) earnings at a glance (GAAP) :
-Earnings: -$33.51 Mln. vs. -$15.99 Mln. last year. -EPS: -$1.93 vs. -$1.96 last year. -Revenue: $1.486 Mln vs. $0.314 Mln last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu OncoCyte Corp When Issuedmehr Nachrichten
Keine Nachrichten verfügbar. |